| Serial Number | 87305763 |
| Word Mark | TOWA PHARMACEUTICAL |
| Filing Date | Wednesday, January 18, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 25, 2020 |
| Registration Number | 6136578 |
| Registration Date | Tuesday, August 25, 2020 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 28, 2017 |
| Goods and Services | Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals(Based on 44(e)) Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals |
| Translation of Words in Mark | The English translation of "TOWA" in the mark is "FOREVER". |
| Disclaimer with Predetermined Text | "PHARMACEUTICAL" |
| Goods and Services | Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 25, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | Sunday, January 1, 2017 |
| First Use In Commerce Date | Tuesday, January 1, 2019 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 25, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, January 1, 2017 |
| First Use In Commerce Date | Tuesday, January 1, 2019 |
| Party Name | Towa Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 571-8580 JP |
| Party Name | Towa Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 571-8580 JP |
| Party Name | Towa Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 571-8580 JP |
| Event Date | Event Description |
| Wednesday, April 20, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, April 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, April 20, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, April 20, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, April 20, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, April 20, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, April 20, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, August 25, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Monday, July 20, 2020 | AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED |
| Saturday, July 18, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, July 17, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, July 16, 2020 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, July 16, 2020 | PETITION GRANTED - RESPONSE RECEIVED |
| Wednesday, July 8, 2020 | ASSIGNED TO PETITION STAFF |
| Monday, May 11, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 11, 2020 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, May 4, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, May 4, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, May 4, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, May 4, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, April 1, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, April 1, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, September 17, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, September 17, 2019 | FINAL REFUSAL E-MAILED |
| Tuesday, September 17, 2019 | SU - FINAL REFUSAL - WRITTEN |
| Tuesday, September 3, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 3, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 29, 2019 | ASSIGNED TO LIE |
| Friday, August 23, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 24, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 24, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, May 24, 2019 | SU - NON-FINAL ACTION - WRITTEN |
| Friday, May 24, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, May 17, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Thursday, May 16, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, May 15, 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, May 10, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Tuesday, May 7, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 7, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, May 6, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Sunday, May 5, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, April 23, 2019 | USE AMENDMENT FILED |
| Sunday, May 5, 2019 | SOU EXTENSION 2 GRANTED |
| Wednesday, January 23, 2019 | SOU EXTENSION 2 FILED |
| Sunday, May 5, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, April 23, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, April 24, 2019 | NOTICE OF REVIVAL - E-MAILED |
| Tuesday, April 23, 2019 | EXTENSION RECEIVED WITH TEAS PETITION |
| Tuesday, April 23, 2019 | PETITION TO REVIVE-GRANTED |
| Tuesday, April 23, 2019 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, February 25, 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, February 25, 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, July 24, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sunday, July 22, 2018 | SOU EXTENSION 1 GRANTED |
| Sunday, July 22, 2018 | SOU EXTENSION 1 FILED |
| Sunday, July 22, 2018 | TEAS EXTENSION RECEIVED |
| Tuesday, January 23, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 28, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 28, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 8, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, October 19, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 17, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 17, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 17, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 18, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 18, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 18, 2017 | NON-FINAL ACTION WRITTEN |
| Thursday, April 13, 2017 | ASSIGNED TO EXAMINER |
| Wednesday, January 25, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, January 21, 2017 | NEW APPLICATION ENTERED IN TRAM |